A randomized pilot clinical trial comparing 5 versus 10 mu g/kg filgrastim (Neupogen) after FEC chemotherapy in order to collect peripheral blood stem cells (PBSC)

Dhondt, Linda; Humblet, Yves; André, Marc; Guillaume, T.; Feyens, Anne Marie; Canon, JL.; Doyen, Chantal; Longueville, Jacques; Vannerom, H; Symann, Michel

A randomized pilot clinical trial comparing 5 versus 10 mu g/kg filgrastim (Neupogen) after FEC chemotherapy in order to collect peripheral blood stem cells (PBSC)

Dhondt, Linda

;

Humblet, Yves

;

André, Marc

;

Guillaume, T.

;

Symann, Michel

;et.al.

(1995)

Files

No attached file found for this publication.

Details

Authors

Dhondt, LindaUCLouvain
Author
Humblet, YvesUCLouvain
Author
André, Marc
Author
Guillaume, T.
Author
Feyens, Anne MarieUCLouvain
Author
Longueville, JacquesUCLouvain
Author
Symann, MichelUCLouvain
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Dhondt, L., Humblet, Y., André, M., Guillaume, T., Feyens, A. M., Canon, JL., Doyen, C., Longueville, J., Vannerom, H., & Symann, M. (1995). A randomized pilot clinical trial comparing 5 versus 10 mu g/kg filgrastim (Neupogen) after FEC chemotherapy in order to collect peripheral blood stem cells (PBSC). European Journal of Cancer, 31A, 355. (Original work published 1995)